Amarin Corp Plc (AMRN)

[CTW1]

Every published article, every conference, every commercial, every educational pamphlet, every physician discussion, every research study outcome brings the benefits of Vascepa out to the public. Share price does not matter at this point. In the years to come most of the general population around the world will be on Vascepa and that is the goal.